ISRAEL INNOVATION PROJECT

BGU study shows that redistributing water sources can increase mating opportunities and strengthen genetic diversity in wild animal populations. By studying a desert-dwelling wild ass population, they showed that adding water sources created new territorial opportunities for males, increasing mating success and gene flow. It is an important and encouraging finding in the context of climate change and ongoing species decline.

Scientists from the Weizmann Institute of Science and Charles University recreated the coronavirus’s evolutionary path in a lab, compressing years of pandemic evolution into just a few months. Using engineered yeast cells and repeated cycles of mutation and selection, the team showed how strong selection pressure can rapidly produce variants resembling Omicron. Researchers say the method could one day help identify dangerous variants before they become dominant, improving pandemic preparedness.

Researchers at Ben-Gurion University are raising concerns about the risks posed by advanced AI systems when their safety safeguards fail. Led by Dr. Michael Fire and Prof. Lior Rokach, the researchers found vulnerabilities across both commercial and publicly accessible AI systems. They call for stronger testing, independent oversight, and regulation to ensure AI innovation develops alongside public safety.

Researchers from the Hebrew University of Jerusalem and the Weizmann Institute of Science have found that the direction of a magnetic field can influence how molecules essential to life behave. Led by Prof. Yossi Paltiel and Prof. Michal Sharon, the study examined L-methionine, an amino acid whose molecular structure may help explain how life’s essential building blocks first developed. The findings suggest that magnetism and electron spin could help explain how early chemical processes shaped biological molecules.

Israeli researchers at the Weizmann Institute of Science have discovered that memory B cells, immune cells traditionally known for remembering viruses and bacteria, can also recognize and target ovarian tumors. Because ovarian cancer is often diagnosed late and remains difficult to treat, the finding could open a new path for cancer immunotherapy. Researchers say the discovery may help advance future vaccines designed to activate the body’s own immune memory against tumors.

Tel Aviv University-launched startup Remilk is advancing cow-free dairy by producing real milk proteins in a lab rather than on a farm. The company now has products on Israeli shelves through a partnership with Gad Dairies. Remilk’s milk is lactose-free, kosher pareve, lower in sugar, and designed to reduce the environmental and industrial costs of traditional dairy production. With FDA approval and international expansion underway, the company aims to make sustainable and nutritious dairy accessible in Israel and beyond.

Israeli doctors at Sheba Medical Center used advanced 3D-printing technology to help treat a woman suffering from a rare “vanishing bone” disease that caused severe bone loss in her leg. They designed a personalized implant and surgical plan to gradually lengthen and reconstruct the damaged bone structure over time. The treatment combined precision imaging, 3D modeling, and staged surgical procedures to restore stability and mobility.

Weizmann-led international team uncovers a specific gene fusion, present in about half of all prostate cancer cases, as a primary driver of treatment resistance. This genetic alteration enables tumors to bypass traditional hormone therapies by switching their dependency from androgens to cortisol, a common stress hormone. To combat this, the team demonstrated that a combination therapy targeting both androgen and cortisol pathways can effectively suppress tumor growth and significantly extend survival. These findings suggest that patients with gene fusion could benefit from combination therapy, which also highlight the need for caution when prescribing steroids.

A new study by researchers at the Hebrew University of Jerusalem found that antibodies transferred from mothers during pregnancy can shape a child’s immune system in ways that provide long-term protection against gum disease. In mouse models, these prenatal antibodies helped program oral immune responses to better control harmful bacteria and prevent inflammation and bone loss later in life. The findings offer a new perspective on the origin of oral diseases.

Researchers from Tel Aviv University received major international recognition after ten faculty members were named Senior Members of the U.S. National Academy of Inventors for 2026, one of the most prestigious recognitions for academic innovation with real-world impact. The honored researchers span fields including neuroscience, AI, cancer research, genomics, bioengineering, and medical imaging, with innovations ranging from autism therapies and cancer diagnostics to safer artificial intelligence systems.